205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.56%
Some net income increase while MCHP is negative at -50.25%. John Neff would see a short-term edge over the struggling competitor.
-2.81%
Negative yoy D&A while MCHP is 17.78%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-345.83%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
5.56%
Less SBC growth vs. MCHP's 63.17%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
101.29%
Slight usage while MCHP is negative at -56.51%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
24.00%
AR growth is negative or stable vs. MCHP's 366.99%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
37.72%
Inventory shrinking or stable vs. MCHP's 180.76%, indicating lean supply management. David Dodd would confirm no demand shortfall.
137.50%
A yoy AP increase while MCHP is negative at -394.61%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
177.03%
Growth well above MCHP's 103.06%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-60.32%
Negative yoy while MCHP is 1034.57%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
63.71%
Some CFO growth while MCHP is negative at -17.43%. John Neff would note a short-term liquidity lead over the competitor.
-27.42%
Negative yoy CapEx while MCHP is 10.91%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-396.50%
Negative yoy purchasing while MCHP stands at 5.07%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
34.44%
We have some liquidation growth while MCHP is negative at -16.41%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-4966.67%
We reduce yoy other investing while MCHP is 49.67%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-88.66%
Both yoy lines negative, with MCHP at -188.84%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
183.82%
We slightly raise equity while MCHP is negative at -100.00%. John Neff sees competitor possibly preserving share count or buying back shares.
16.35%
Buyback growth of 16.35% while MCHP is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.